Diagnosis and treatment of pericarditis

### Learning objectives 1. Review the definitions, classification and aetiology of pericarditis. 2. Describe the clinical presentation, diagnostic criteria and work-up, laboratory and imaging findings of pericarditis. 3. Review and describe the contemporary medical, interventional and surgical therapies, the prevention and prognosis of pericarditis. ### Classification and definition Pericarditis is an inflammatory disease of the pericardium, which may have infectious or non-infectious causes, and is manifested by a combination or signs (ie, pericardial rubs, electrocardiographic changes and pericardial effusion), symptoms (mainly chest pain but possible additional symptoms such as dyspnoea) and usually elevation of markers of myocardial inflammation (ie, protein C reactive).1–6 A concomitant myocardial involvement has been described in about one-third of patients with acute pericarditis and it is due to overlapping aetiological agents for pericarditis and myocarditis. In clinical practice it is often detected by elevation of markers of myocardial lesion (ie, troponins) assessed for the differential diagnosis with an acute coronary syndrome. These cases usually with preserved left ventricular function are commonly labeled as myopericarditis.7 ,8 The disease may present as an isolated process or as a part of another disease with pericardial involvement (ie, systemic inflammatory disease and lung cancer) thus involving different medical specialties (ie, cardiology, internal medicine, rheumatology, oncology and nephrology).6 Specific terminology has been adopted in clinical studies as well as guidelines and reviews and will be briefly reviewed in order to promote standardised definitions. Acute pericarditis is the first attack of pericarditis, generally occurring with an acute onset of symptoms. Treatment of the episode generally lasts for 4–6 weeks, considering the attack dose and drug tapering. If the patient does not reach a remission and the disease lasts several weeks or months without a symptoms-free interval of 4–6 weeks, the term incessant pericarditis is adopted. If the disease reappears after a symptom-free interval of 4–6 weeks, the term recurrent or relapsing pericarditis is …

[1]  Amjad M Ahmed,et al.  Multimodality Imaging of Pericardial Diseases , 2017, Current Treatment Options in Cardiovascular Medicine.

[2]  Y. Adler,et al.  Prognosis of myopericarditis as determined from previously published reports , 2014, Journal of cardiovascular medicine.

[3]  Y. Adler,et al.  Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014 – systematic review and meta-analysis , 2014, Journal of cardiovascular medicine.

[4]  Y. Pinto,et al.  Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2014, European heart journal.

[5]  Y. Adler,et al.  Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial , 2014, The Lancet.

[6]  A. Martini,et al.  Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. , 2014, The Journal of pediatrics.

[7]  L. Punzi,et al.  The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up. , 2014, Seminars in arthritis and rheumatism.

[8]  Massimo Imazio Tratamiento de la pericarditis recurrente , 2014 .

[9]  Matthew J Snyder,et al.  Acute pericarditis: diagnosis and management. , 2014, American family physician.

[10]  Juan Cinca,et al.  New electrocardiographic criteria to differentiate acute pericarditis and myocardial infarction. , 2014, The American journal of medicine.

[11]  I. Simsek,et al.  A randomized trial of colchicine for acute pericarditis. , 2014, The New England journal of medicine.

[12]  B. Mayosi,et al.  Myopericarditis in tuberculous pericardial effusion: prevalence, predictors and outcome , 2013, Heart.

[13]  E. Fabris,et al.  Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. , 2013, The American journal of cardiology.

[14]  Y. Adler,et al.  A randomized trial of colchicine for acute pericarditis. , 2013, The New England journal of medicine.

[15]  Richard D. White,et al.  American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[16]  G. Ligabue,et al.  Good Prognosis for Pericarditis With and Without Myocardial Involvement: Results From a Multicenter, Prospective Cohort Study , 2013, Circulation.

[17]  A. Petrilli,et al.  [First guidelines on pediatric cardio-oncology from the Brazilian Society of Cardiology]. , 2013, Arquivos brasileiros de cardiologia.

[18]  H. Schaff,et al.  Surgery for pericardial disease , 2013, Heart Failure Reviews.

[19]  Y. Adler,et al.  Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis , 2013, Heart Failure Reviews.

[20]  B. Mayosi,et al.  Tuberculous pericarditis with and without HIV , 2013, Heart Failure Reviews.

[21]  L. S. Lilly Treatment of acute and recurrent idiopathic pericarditis. , 2013, Circulation.

[22]  Y. Adler,et al.  Management of pericardial effusion. , 2013, European heart journal.

[23]  L. Cooper,et al.  Management of myopericarditis , 2013, Expert review of cardiovascular therapy.

[24]  H. Schaff,et al.  Pericardiectomy vs medical management in patients with relapsing pericarditis. , 2012, Mayo Clinic proceedings.

[25]  C. Tsioufis,et al.  Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra). , 2012, International journal of cardiology.

[26]  M. Imazio Treatment of recurrent pericarditis , 2012, Expert review of cardiovascular therapy.

[27]  D. Spodick Colchicine effectively and safely treats acute pericarditis and prevents and treats recurrent pericarditides , 2012, Heart.

[28]  M. Imazio Contemporary management of pericardial diseases , 2012, Current opinion in cardiology.

[29]  M. Imazio Pericardial involvement in systemic inflammatory diseases , 2011, Heart.

[30]  G. Keren,et al.  Diagnostic Yield of Extensive Infectious Panel Testing in Acute Pericarditis , 2011, Cardiology.

[31]  C. Stefanadis,et al.  Extensive Infectious Panel Testing for Acute Pericarditis: A Ghost Hunt? , 2011, Cardiology.

[32]  Y. Adler,et al.  Risk of Constrictive Pericarditis After Acute Pericarditis , 2011, Circulation.

[33]  M. Imazio Evaluation and management of pericarditis , 2011, Expert review of cardiovascular therapy.

[34]  M. Galeazzi,et al.  Autoinflammatory diseases and cardiovascular manifestations , 2011, Annals of medicine.

[35]  F. Cinetto,et al.  Azathioprine in isolated recurrent pericarditis: a single centre experience. , 2011, International journal of cardiology.

[36]  A. Brucato,et al.  Prevalence of C-Reactive Protein Elevation and Time Course of Normalization in Acute Pericarditis: Implications for the Diagnosis, Therapy, and Prognosis of Pericarditis , 2011, Circulation.

[37]  G. Biondi-Zoccai,et al.  International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. , 2010, American heart journal.

[38]  Y. Adler,et al.  Medical therapy of pericardial diseases: Part II: Noninfectious pericarditis, pericardial effusion and constrictive pericarditis , 2010, Journal of cardiovascular medicine.

[39]  Y. Adler,et al.  Diagnostic issues in the clinical management of pericarditis , 2010, International journal of clinical practice.

[40]  M. Desai,et al.  The Role of Multimodality Imaging in the Management of Pericardial Disease , 2010, Circulation. Cardiovascular imaging.

[41]  Y. Adler,et al.  Individualized therapy for pericarditis , 2009, Expert review of cardiovascular therapy.

[42]  Y. Adler,et al.  Aetiological diagnosis in acute and recurrent pericarditis: when and how , 2009, Journal of cardiovascular medicine.

[43]  Y. Adler,et al.  Colchicine for pericarditis: hype or hope? , 2009, European heart journal.

[44]  G. Brambilla,et al.  Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation , 2008, Circulation.

[45]  D. Spodick Risk prediction in pericarditis: who to keep in hospital? , 2007, Heart.

[46]  Y. Adler,et al.  Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. , 2007, The American journal of cardiology.

[47]  M. Imazio,et al.  Myopericarditis versus viral or idiopathic acute pericarditis , 2007, Heart.

[48]  M. Imazio,et al.  Triage and management of acute pericarditis. , 2007, International journal of cardiology.

[49]  L. Coda,et al.  Indicators of Poor Prognosis of Acute Pericarditis , 2007, Circulation.

[50]  Eloisa Arbustini,et al.  Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[51]  Y. Adler,et al.  Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. , 2006, The American journal of cardiology.

[52]  P. Seidenberg,et al.  Pericarditis: Diagnosis, management, and return to play , 2006, Current sports medicine reports.

[53]  J. Soler‐Soler,et al.  Relapsing pericarditis , 2004, Heart.

[54]  M. Imazio,et al.  Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. , 2004, Journal of the American College of Cardiology.

[55]  G. Permanyer-Miralda Acute pericardial disease: approach to the aetiologic diagnosis , 2004, Heart.

[56]  B. Hoit Management of effusive and constrictive pericardial heart disease. , 2002, Circulation.

[57]  Cayetano Permanyer Miralda,et al.  Guías de práctica clínica de la Sociedad Española de Cardiología en patología pericárdica , 2000 .

[58]  T. Gardner,et al.  The effective treatment of postpericardiotomy syndrome after cardiac operations. A randomized placebo-controlled trial. , 1990, The Journal of thoracic and cardiovascular surgery.

[59]  M. Imazio Guidelines on the Management of Pericardial Diseases , 2016 .

[60]  C. Rochitte,et al.  I BrazIlIan GuIdelInes on MyocardItIs and PerIcardItIs , 2013 .

[61]  D. Spodick,et al.  Contemporary Reviews in Cardiovascular Medicine Controversial Issues in the Management of Pericardial Diseases , 2010 .

[62]  M. Cheitlin Long-Term Outcomes in Difficult-to-Treat Patients With Recurrent Pericarditis , 2007 .

[63]  M. Yacoub,et al.  [Guidelines on the diagnosis and management of pericardial diseases. Executive summary]. , 2004, Revista espanola de cardiologia.

[64]  D. Rosing Effusive-constrictive pericarditis. , 2004, The New England journal of medicine.

[65]  Matthew W. Miller Pericardial Diseases , 2002 .

[66]  L. Almenar Bonet,et al.  [The clinical practice guidelines of the Sociedad Española de Cardiología on pericardial pathology]. , 2000, Revista espanola de cardiologia.